Skip over navigation

News & Events

Newsroom


	Study strengthens link between Epstein-Barr virus and multiple sclerosis April 23, 2024 - “Our findings help confirm a strong relationship between MS and the Epstein-Barr virus across the lifespan, which could be a new target for treatment and prevention.”


	Which cells have the greatest potential to repair the lungs of pre-term babies? April 23, 2024 - Dr. Bernard Thébaud and his team have uncovered which types of mesenchymal stromal cells (MSCs) are the best at healing lung injury in the lab.


	Non-invasive brain stimulation shows promise in reducing psychological distress in advanced illness April 8, 2024 - A small clinical trial at The Ottawa Hospital and Bruyère has shown for the first time that repetitive transcranial magnetic stimulation (rTMS) holds promise as a treatment for psychological distress in people with advanced illness.


	The Ottawa Hospital appoints new leader for research and innovation April 2, 2024 - The Ottawa Hospital (TOH) is delighted to announce the appointment of Dr. Rebecca Auer as Executive Vice-President of Research and Innovation at TOH and CEO and Scientific Director of the hospital’s research institute (OHRI).


	Are EVs travelling to injured lungs? March 15, 2024 - Tiny particles called extracellular vesicles (EVs) released by mesenchymal stem cells (MSCs) have shown clear potential to treat several lung diseases in animal models by reducing inflammation. However, there has been debate about where MSC-EVs ...

See all news items \| See only press releases \| Search for news and experts by disease / specialty

Media contacts

Amelia Buchanan
Senior Communication Specialist
613-297-8315
ambuchanan@ohri.ca

Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca